T1	Participants 80 116	patients with advanced breast cancer
T2	Participants 382 430	patients with breast cancer with bone metastases
T3	Participants 1687 1733	patients with breast cancer metastatic to bone
T4	Participants 1912 1942	patients with bone metastases.
